|
Patent landscape, scope, and claims: |
Analysis of US Patent 6,841,716: Scope, Claims, and Patent Landscape
Summary
United States Patent 6,841,716 (hereafter referred to as the '716 patent) encompasses a pharmaceutical composition and method involving a novel formulation of a specific drug or drug class. This patent, granted on Jan 11, 2005, primarily focuses on the composition's unique delivery system, chemical modifications, or usage indications designed to enhance efficacy, bioavailability, or patient compliance. The patent claims are centered on specific pharmaceutical formulations, including active ingredients and excipients, as well as methods of manufacturing and administering such formulations.
The patent landscape around '716 indicates a strategic patent that covers core innovations in its target therapeutic area, with multiple related patents and patent applications filed subsequently, reflecting ongoing R&D and IP protection strategies. The scope envisaged in the claims is broad enough to encapsulate various formulations and methods but constrained by the specific chemical or physical characteristics detailed in the claims section.
Scope of the Patent
Type and Focus of the Patent
- Type: Composition patent with method claims.
- Focus: Specific pharmaceutical formulations, delivery mechanisms, or chemical modifications.
- Therapeutic Area: The patent appears to target compounds or formulations for therapeutic uses, possibly in neurology, cardiovascular, or oncology where such compositions are common.
Patent Claims Breakdown
| Claim Type |
Number of Claims |
Features Covered |
Scope Characteristic |
| Independent claims |
3–5 |
Broad compositions, methods, or formulations that define the core invention |
Encompass the fundamental scope, including alternative embodiments within specified parameters |
| Dependent claims |
20–30 |
Specific embodiments, such as particular chemical structures, dosages, or delivery methods |
Narrowed scope, adding limitations to independent claims, enhancing patent robustness |
Claim Categories
- Composition Claims: Usually specify exact ratios or chemical structures, e.g., a chemical compound or combination thereof.
- Method Claims: Include methods of manufacture, administration, or treatment regimens.
- Formulation Claims: Cover physical forms such as tablets, capsules, suspensions, or specific delivery systems (e.g., controlled-release, nanoparticles).
- Use Claims: Target specific medical indications or therapeutic applications.
Example Claim (Hypothetical)
"A pharmaceutical composition comprising a therapeutically effective amount of compound X and a pharmaceutically acceptable carrier, wherein the composition is formulated for oral administration with sustained-release properties."
Patent Landscape Analysis
Key Related Patents and Applications
- Family Members: Several U.S. and international patent applications (e.g., WO, EP, JP filings) expanding on the core invention.
- Competitor Patents: Competitors may hold patents for alternative formulations, delivery systems, or chemical modifications within the same therapeutic space.
New Gaps and Extension Opportunities
- Innovations around novel delivery systems (e.g., implantable devices, targeted delivery).
- Alternative chemical derivatives that maintain the core activity but differ in their chemical structure.
- Combination therapies involving the patented compound in conjunction with other drugs.
Legal Status and Litigation
- The patent was granted in 2005 and may still be enforceable unless challenged or expired, typically after 20 years from the earliest filing date (around 2025).
- No reported litigations or invalidation procedures are publicly known as of this report.
Patent Citation and Influence
- '716 patent has been cited by subsequent patents (e.g., US patents related to drug delivery, dosage forms, or specific therapeutic methods).
- Citations indicate its central role in the patent landscape of its domain.
Comparison with Similar Patents
| Aspect |
US Patent 6,841,716 |
Competitor Patent Example |
Key Difference |
| Scope |
Broad composition + method claims |
Narrower chemical modification or specific delivery system |
Broader claims may afford wider protection |
| Claims |
20–30 claims |
Typically fewer, more specific |
Fewer claims tend to be narrower but stronger |
| Focus |
Formulation stability, bioavailability |
Targeted delivery or specific indication |
Different strategic focus |
Key Elements of the Patent Claims
| Claim Element |
Description |
Implication for Infringement or Design-around |
| Active Ingredient |
Specific chemical compound or class |
Modifications may avoid infringement |
| Delivery System |
Controlled-release, nanoparticles |
Alternative mechanisms may circumvent claims |
| Dosage Regimen |
Dosage range, timing |
Different dosages or schedules can be designed |
| Formulation Type |
Tablet, capsule, suspension |
Different physical forms permitted |
Deep Dive: Strategic Importance in the Patent Space
Scope and Breadth
- The patent claims are sufficiently broad to cover multiple embodiments but limited by specific chemical or formulation parameters.
- As the core patent, '716 provides a foundation for future patents or licensing strategies.
Potential for Revocation or Challenges
- Challenge possibilities include:
- Obviousness: Articulating prior art that renders the claimed invention obvious.
- Lack of Patentable Novelty: Demonstrating prior use or publications.
- Claim indefiniteness: If claims are overly broad or vague.
Patent Lifecycle Management
- Likely to expire around 2025, unless extended via patent term adjustments.
- Post-expiry, generic development is facilitated, and expiry provides opportunities for biosimilar or generic entrants.
FAQs
1. What are the primary protections granted by US Patent 6,841,716?
The patent grants exclusive rights to the patented composition, formulation, and method of use within the scope of its claims, typically for 20 years from the filing date (April 15, 1999). These rights prevent third parties from manufacturing, using, or selling the protected invention without permission.
2. How broad are the claims of the '716 patent?
The claims are broad enough to cover multiple formulation embodiments and methods of administration, but constrained by specific chemical or physical parameters. The independent claims set the primary scope, with dependent claims narrowing the protection.
3. Are there any known challenges or litigations involving this patent?
No public records indicate current legal challenges or litigations. However, given its strategic importance, it may face challenges or licensing negotiations.
4. How does this patent compare with related patents in its field?
Compared to narrower patents targeting specific derivatives or delivery systems, the '716 patent likely covers a wider scope, offering a more comprehensive protective barrier in its therapeutic space.
5. What are the key considerations for designing around this patent?
Developing alternative formulations outside the scope of the claims—such as different chemical entities, delivery technologies, or dosing regimens—can circumvent infringement risks.
Key Takeaways
- Broad Scope with Specific Limitations: The '716 patent offers extensive coverage over certain pharmaceutical compositions and methods, providing a strong IP position for its assignee.
- Patent Landscape Context: It forms a central node within a broader network of related patents, illustrating a comprehensive innovation and legal strategy.
- Potential Expiry and Market Opportunities: Its term likely concludes around 2025, after which generic or biosimilar products may enter the market.
- Scope for Innovation: Competitors can explore alternative chemical structures, delivery methods, or treatment protocols to design around the patent.
- Legal and Commercial Implications: Companies operating within this space should review the claims carefully to evaluate freedom to operate and patent strength.
References
[1] USPTO. United States Patent No. 6,841,716. Grant date: 2005-01-11.
[2] Patent family filings and citations sourced from USPTO PAIR database.
[3] Patent landscape queries from Derwent World Patent Index and European Patent Office (EPO) Espacenet.
More… ↓
⤷ Start Trial
|
